Jinjiang Medical's Innovative PFA Catheter for Paroxysmal Supraventricular Tachycardia Gains NMPA Approval

Apr 21, 2025 18:00 CST Updated 18:00

Jinjiang Electronic

Developer of electrophysiology products

NMPA Announced TodaySichuan Jinjiang Electronic Science and Technology Co.,Ltd.Single-use Magnetic Localization Pressure Monitoring Pulsed Electric Field Ablation Catheter Launch. Product Indications:Mainly used for the treatment of paroxysmal supraventricular tachycardia。

Product Composition

Jinjiang ElectronicThe magnetic positioning pressure monitoring PFA product consists of a tip, tube body, handle, and connecting cable, and needs to be used withUsed in conjunction with Jinjiang Electronic's cardiac pulse ablation instrument.

Innovation Points

Jinjiang ElectronicMagnetic positioning pressure monitoring PFA products achieve innovative design through the ablation tip structure,Achieve precise application of high-voltage pulse energy sources on target tissues。Magnetic Localization Pressure Monitoring PFABy adopting a multi-electrode setup in localized areas, the ablation tip's adaptability to various complex and delicate tissue structures is enhanced while enabling real-time display of catheter position and tip pressure monitoring values, effectively improving surgical efficiency and reducing the risk of cardiac perforation complications for patients.。

Jinjiang Electronic is one of the earliest companies in China to launch PFA products and also the first electrophysiology company approved for marketing by NMPA. On December 27, 2023, Jinjiang ElectronicLEAD-PFAPulse Ablation System (Device + Catheter) Approved for Marketing, Officially Opening the PFA Era in Electrophysiology in China.LEAD-PFAThe pulsed ablation system is of great significance to China's electrophysiology, as it is one of the few fields where Chinese products have outpaced overseas giants to be the first to market.Companies like Jinjiang Electronic and Denovo Electrophysiology have worked hard to ensure that China's electrophysiology field did not become a marginal participant in the PFA era as it was during the thermal ablation era, but instead emerged as a main driver of the PFA revolution. In the future, companies such as Boston Scientific, Medtronic, Johnson & Johnson, and even Abbott will no longer dominate China's electrophysiology market as they did during the thermal ablation era. This is an era of electrophysiology that belongs to China.

LEAD-PFA OnHas set a good start, nowMagnetic Positioning Pressure Monitoring PFA Product ContinuationJinjiang Electronic This momentum. It is the first to be approved for use inPFA Products for the Treatment of Paroxysmal Supraventricular Tachycardia. Looking ForwardFutureChinese PFA companies continue to launch innovative PFA products, further expanding their market presence.